JP2024516316A5 - - Google Patents

Info

Publication number
JP2024516316A5
JP2024516316A5 JP2023568440A JP2023568440A JP2024516316A5 JP 2024516316 A5 JP2024516316 A5 JP 2024516316A5 JP 2023568440 A JP2023568440 A JP 2023568440A JP 2023568440 A JP2023568440 A JP 2023568440A JP 2024516316 A5 JP2024516316 A5 JP 2024516316A5
Authority
JP
Japan
Prior art keywords
kynurenine
molecular weight
low molecular
hydroxy
weight compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516316A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050722 external-priority patent/WO2022232950A1/en
Publication of JP2024516316A publication Critical patent/JP2024516316A/ja
Publication of JP2024516316A5 publication Critical patent/JP2024516316A5/ja
Pending legal-status Critical Current

Links

JP2023568440A 2021-05-07 2022-05-09 萎縮性瘢痕を治療するためのキヌレニンおよびその誘導体 Pending JP2024516316A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163185994P 2021-05-07 2021-05-07
US63/185,994 2021-05-07
PCT/CA2022/050722 WO2022232950A1 (en) 2021-05-07 2022-05-09 Kynrenine and derivatives thereof for treating atrophic scarring

Publications (2)

Publication Number Publication Date
JP2024516316A JP2024516316A (ja) 2024-04-12
JP2024516316A5 true JP2024516316A5 (cg-RX-API-DMAC7.html) 2025-05-07

Family

ID=83932596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568440A Pending JP2024516316A (ja) 2021-05-07 2022-05-09 萎縮性瘢痕を治療するためのキヌレニンおよびその誘導体

Country Status (10)

Country Link
US (1) US20240226085A1 (cg-RX-API-DMAC7.html)
EP (1) EP4322936A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024516316A (cg-RX-API-DMAC7.html)
KR (1) KR20240004954A (cg-RX-API-DMAC7.html)
CN (1) CN117651553A (cg-RX-API-DMAC7.html)
AU (1) AU2022269054A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023023213A2 (cg-RX-API-DMAC7.html)
CA (1) CA3216907A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023013100A (cg-RX-API-DMAC7.html)
WO (1) WO2022232950A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119950473B (zh) * 2025-03-04 2026-01-27 中国海洋大学 L-犬尿氨酸在制备预防和/或治疗紫外光诱导的皮肤光损伤的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102018A (ja) * 1987-10-16 1989-04-19 Sogo Yatsukou Kk 化粧料
JP2000264827A (ja) * 1999-03-16 2000-09-26 Saburo Uchikuga アウトドア化粧料
JP2002053448A (ja) * 2000-07-28 2002-02-19 Pentapharm Ltd アウトドア化粧料
KR20100057061A (ko) * 2007-09-11 2010-05-28 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 maippkknqdk (소 카파 카세인 106-116)및/또는 ygfqna (세로르핀)의 용도
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
SG11201510003VA (en) * 2013-06-05 2016-01-28 Univ British Columbia Anti-fibrogenic compounds, methods and uses thereof
KR102221499B1 (ko) * 2013-09-26 2021-03-02 갈데르마 소시에떼아노님 위축성 피부 흉터를 치료하기 위한 프로스타글라딘 F2α 및 그 유사체
FR3042710B1 (fr) * 2015-10-22 2019-12-13 Jean-Noel Thorel Composition a base de dihydromyricetine et d'un sel de zinc pour le traitement de l'acne et des peaux grasses
WO2018136884A1 (en) * 2017-01-23 2018-07-26 The Regents Of The University Of California Compositions and methods for treating obesity and inducing weight loss
EP3796976A4 (en) * 2018-05-23 2022-03-30 Epitracker, Inc. COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO LONGEVITY AND QUALITY OF AGING

Similar Documents

Publication Publication Date Title
US3988470A (en) Treatment of palmar and plant disturbed keratosis
JP2005508936A5 (cg-RX-API-DMAC7.html)
CA2461941A1 (en) Anti-irritating rosacea treatment
JP2005518359A (ja) フェニル−グリシン誘導体を含む組成物
WO2011056667A2 (en) Rosacea topical skin treatment method and formulation
CN111372595A (zh) 治疗皮肤的方法和组合物
US20050136085A1 (en) Panthenol and natural organic extracts for reducing skin irritation
US11266588B2 (en) Skin treatment methods and compositions with retinoid and delivery systems thereof
TWI535449B (zh) 到手香萃取物於製備改善痤瘡之組成物之用途
US20200030398A1 (en) Skin care composition
EP2928460B1 (en) Methods for preventing and treating inflammatory skin conditions
WO2009101497A2 (en) Topical pharmaceutical combination comprising minoxidil and aminexil
JP2016501236A5 (cg-RX-API-DMAC7.html)
DK2431030T3 (en) Treatment of fungal infections
US12440436B1 (en) Face peel formulation and method of application
US11576850B1 (en) Face peel formulation and method of application
KR100441059B1 (ko) 두피 및 모발 상태의 개선을 위한 조성물
CN114306152A (zh) 一种发用控油组合物及其应用
JPS6172707A (ja) にきび用化粧料
CA3052863C (en) Composition and method for forming a composition for increasing dermal nitric oxide
US9757326B2 (en) Hair rejuvenating lotion
JP2007537165A (ja) ストレッチマーク用の局所用イトスギ精油組成物
JPWO2025142805A5 (cg-RX-API-DMAC7.html)
JP2025527769A (ja) 皮膚の夜間修復に関連する機能を高めるための組成物の使用
JPH0881375A (ja) 角質溶解剤